Anticancer method comprising plant stem cell line derived from
The present invention relates to a composition for preventing or treating cancer, which contains, as an active ingredient, a Taxus cambium- or procambium-derived cell line; a lysate thereof; an extract thereof; or a culture medium thereof. The cell line, the lysate, the extract, and the culture medium has minimized side effects compared to the conventional therapeutic drugs, is safe to the human body, is involved directly in the growth of cancer to induce cancer cell death, and shows anticancer activity of inhibiting angiogenesis occurring in carcinogenesis. Accordingly, the cell line, the lysate, the extract and the culture medium is useful for the prevention, treatment and alleviation of cancer.
1. A method for treating cancer, comprising administering any one or more selected from the group consisting of a cell line, a cell lysate, an extract of a cell line, and a culture of a cell line, wherein the cell line, the cell lysate, the extract of the cell line, and the culture medium of the cell line are all free of taxol, wherein said cell line is isolated from a cambium or procambium of Taxus and has the following characteristics:
(a) being in an innately undifferentiated state without going through dedifferentiation and being not a callus; and
(b) being a homogeneous cell line.
2. The method for treating cancer according to claim 1 , wherein the cell line is additionally characterized in that: (a) it is present as single cells during suspension culture; (b) it has a growth rate higher than those of cell lines derived from tissues other than the cambium or procambium of Taxus ; (c) it has low sensitivity to shear stress in a bioreactor compared to cell lines derived from tissues other than the cambium or procambium of Taxus ; and (d) it has multiple vacuoles morphologically.
3. The method for treating cancer according to claim 1 , wherein the cell line is obtained using an isolation method comprising the following steps of:
(a) obtaining a Taxus cambium- or procambium-containing tissue;
(b) inducing a cambium or procambium layer proliferated from the cambium or pro cambium and an amorphous callus layer proliferated from tissues other than the cambium or procambium by culturing the obtained Taxus cambium- or procambium-containing tissue; and
(c) collecting a cell line from the cambium or procambium layer.
4. The method for treating cancer according to claim 3 , wherein the step (c) is performed by proliferating cell line in a medium, which contains 3-5 wt % of mw sugar or sugar and at least one substance selected from the group consisting of methyl jasmonate, fungal extract, bacterial extract, yeast extract, chitosan, glucomanan, glucan, phenylalanine, benzoic acid, salicylic acid, arachonic acid, Staurosporine (STS), mevalonalonate N-benzolyglycine, Abscisic acid (ABA), Sodium nitroprusside (SNP), Isopentenylpyrophosphate (IPP), Butylated hydroxytoluene (BHT), 2-chloroethyl trimethylammonium chloride (CCC), ethephon, hippuic acid, ammonium ceric nitrate, AgNO 3 , vanadyl sulfate, p-aminobenzoic acid, brassinosteroids, sodium alginate, and sodium acetate, and then collecting the cell line proliferated in the medium.
5. The method for treating cancer according to claim 1 , wherein the extract is obtained using a solvent selected from the group consisting of distilled water, alcohol, acetone, DMSO (dimethyl sulfoxide), and mixed solvents thereof.
6. The method for treating cancer according to claim 1 , wherein the cancer is selected from the group consisting of colon cancer, oral cavity carcinoma, lung cancer, prostate cancer, osteosarcoma, leukemia, uterine cancer, skin cancer, pancreatic cancer, breast cancer, gastric cancer, renal cancer and liver cancer.
7. The method for treating cancer according to claim 1 , wherein the administering of the any one or more selected from the group consisting of a cell line, a lysate of a cell line, an extract of a cell line, and a culture of a cell line, wherein the cell line, the cell lysate, the extract of the cell line, and the culture medium of the cell line are all free of taxol, is done orally.
8. A method for improving a cancer patient condition, comprising orally administering food, wherein the food contains any one or more selected from the group consisting of a cell line, a lysate of a cell line, an extract of a cell line, and a culture of a cell line, wherein the cell line, the cell lysate, the extract of the cell line, and the culture medium of the cell line are all free of taxol, wherein said cell line is isolated from a cambium or pro cambium of Taxus and has the following characteristics:
(a) being in an innately undifferentiated state without going through dedifferentiation and being not a callus; and
(b) being a homogeneous cell line.
9. The method improving a cancer patient condition according to claim 8 , wherein the cell line is additionally characterized in that: (a) it is present as single cells during suspension culture; (b) it has a growth rate higher than those of cell lines derived from tissues other than the cambium or procambium of Taxus ; (c) it has low sensitivity to shear stress in a bioreactor compared to cell lines derived from tissues other than the cambium or procambium of Taxus ; and (d) it has multiple vacuoles morphologically.
10. The method for improving a cancer patient condition according to claim 8 , wherein the cell line is obtained using an isolation method comprising the following steps of
(a) obtaining a Taxus cambium- or procambium-containing tissue;
(b) inducing a cambium or procambium layer proliferated from the cambium or pro cambium and an amorphous callus layer proliferated from portions other than the cambium or pro cambium by culturing the obtained Taxus cambium- or procambium-containing tissue; and
(c) collecting a cell line from the cambium or procambium layer.